New pill could tame severe gut disease
NCT ID NCT05486104
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called Hemay005 for people with moderate to severe ulcerative colitis, a chronic gut condition. About 92 participants will receive either a low dose, high dose, or a placebo for 12 weeks. The goal is to see if the drug can reduce symptoms like diarrhea and bleeding, and help the gut heal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Chaoyang Hospital Affiliated to Capital Medical University
Beijing, China
-
Beijing Friendship Hospital Affiliated to Capital Medical University
Beijing, China
-
Chongqing People's Hospital
Chongqing, China
-
First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
Peking University Third Hospital
Beijing, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, China
-
Shandong Provincial Hospital
Jinan, Shandong, China
-
Shanghai Oriental Hospital
Shanghai, China
-
Shengjing Hospital Affiliated to China Medical University
Shenyang, Liaoning, China
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
The Fourth Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
Tianjin Medical University General Hospital
Tianjin, China
-
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame ulcerative colitis?
- Could a new injection tame ulcerative colitis?
- New study explores simple tests to replace colonoscopies for colitis patients
- New drug shows promise for ulcerative colitis sufferers
- Immune cell therapy takes on IBD: a new hope for tough cases?
- New drug vixarelimab tested for Tough-to-Treat ulcerative colitis